214 related articles for article (PubMed ID: 9307673)
1. Saquinavir in the management of HIV infection.
Moyle G
Br J Hosp Med; 1997 Jun 4-17; 57(11):560-4. PubMed ID: 9307673
[TBL] [Abstract][Full Text] [Related]
2. Virological efficacy and plasma drug concentrations of nelfinavir plus saquinavir as salvage therapy in HIV-infected patients refractory to standard triple therapy.
Reiser M; Salzberger B; Stiepel A; Hoetelmans R; Diehl V; Fätkenheuer G
Eur J Med Res; 1999 Feb; 4(2):54-8. PubMed ID: 10066640
[TBL] [Abstract][Full Text] [Related]
3. Salvage therapy for patients failing their current antiretroviral regimen.
Albrecht MA
AIDS Clin Rev; 2000-2001; ():139-91. PubMed ID: 10999220
[No Abstract] [Full Text] [Related]
4. Practical issues regarding the use of antiretroviral therapy for HIV infection.
Deeks SG
West J Med; 1998 Feb; 168(2):133-9. PubMed ID: 9499754
[TBL] [Abstract][Full Text] [Related]
5. Rationale and experience with reverse transcriptase inhibitors and protease inhibitors.
Vella S
J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S58-61. PubMed ID: 8595511
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy in the management of HIV infection.
Vella S; Franca Pirillo M
Methods Find Exp Clin Pharmacol; 1996; 18 Suppl C():23-6. PubMed ID: 9003571
[No Abstract] [Full Text] [Related]
7. [HIV protease inhibitors. A new drug class in antiretroviral therapy].
Mauss S; Seidlitz B; Jablonowski H; Häussinger D
Dtsch Med Wochenschr; 1996 Nov; 121(44):1369-74. PubMed ID: 8964223
[No Abstract] [Full Text] [Related]
8. Long-term efficacy and safety of twice-daily saquinavir soft gelatin capsules (SGC), with or without nelfinavir, and three times daily saquinavir-SGC, in triple combination therapy for HIV infection: 100-week follow-up.
Greenberg RN; Feinberg J; Goodrich J; Pilson RS; Siemon-Hryczyk P
Antivir Ther; 2003 Feb; 8(1):37-42. PubMed ID: 12713062
[TBL] [Abstract][Full Text] [Related]
9. Rational approaches to resistance: using saquinavir.
Boucher C
AIDS; 1996 Nov; 10 Suppl 1():S15-9. PubMed ID: 8970671
[TBL] [Abstract][Full Text] [Related]
10. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
[TBL] [Abstract][Full Text] [Related]
11. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
12. Failure of double protease inhibitor therapy as a salvage therapy for HIV-infected patients resistant to conventional triple therapy.
Rockstroh JK; Altfeld M; Kupfer B; Kaiser R; Fätkenheuer G; Salzberger B; Schneweis KE; Spengler U
Eur J Med Res; 1999 Jul; 4(7):271-4. PubMed ID: 10425264
[TBL] [Abstract][Full Text] [Related]
13. [The combination of saquinavir and ddC ensures longer survival].
Hoof T
Dtsch Med Wochenschr; 1996 Sep; 121(37):A30. PubMed ID: 8925721
[No Abstract] [Full Text] [Related]
14. Ritonavir-saquinavir dual protease inhibitor compared to ritonavir alone in human immunodeficiency virus-infected patients.
Michelet C; Ruffault A; Sébille V; Arvieux C; Jaccard P; Raffi F; Bazin C; Chapplain JM; Chauvin JP; Dohin E; Cartier F; Bellissant E
Antimicrob Agents Chemother; 2001 Dec; 45(12):3393-402. PubMed ID: 11709314
[TBL] [Abstract][Full Text] [Related]
15. Protease inhibitors: resistance, resistance, resistance.
Gilden D; Falkenberg J; Torres G
GMHC Treat Issues; 1997 Feb; 11(2):5-10. PubMed ID: 11364108
[TBL] [Abstract][Full Text] [Related]
16. Data in from first head-to-head protease inhibitor.
AIDS Patient Care STDS; 1998 Apr; 12(4):317. PubMed ID: 11361961
[No Abstract] [Full Text] [Related]
17. Plasma and cerebrospinal fluid saquinavir concentrations in patients receiving combination antiretroviral therapy.
Moyle GJ; Sadler M; Buss N
Clin Infect Dis; 1999 Feb; 28(2):403-4. PubMed ID: 10064262
[No Abstract] [Full Text] [Related]
18. Antiretroviral update: recent advances expand options for patients with HIV.
Santhanam H; Goins M
Adv Nurse Pract; 2004 Nov; 12(11):53-4, 56. PubMed ID: 15559568
[No Abstract] [Full Text] [Related]
19. Management of HIV infection in Nigeria with zalcitabine in combination with saquinavir mesylate: preliminary findings.
Akinsete I; Njoku OS; Okanny CC; Chukwuani CM; Akanmu AS;
West Afr J Med; 2000; 19(4):265-8. PubMed ID: 11391837
[TBL] [Abstract][Full Text] [Related]
20. [HIV protease inhibitors].
Rubio R; Romeu J; Viciana P; Redondo C
Enferm Infecc Microbiol Clin; 1996 Oct; 14 Suppl 1():10-4. PubMed ID: 9053020
[No Abstract] [Full Text] [Related]
[Next] [New Search]
